Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1‑year results from the Japan subgroup of the phase 3 YOSEMITE trial

Shimura Masahiko and Kitano Shigehiko and Ogata Nahoko and Mitamura Yoshinori and Oh Hideyasu and Kollaborációs szervezet: YOSEMITE and RHINE Investigators and Bátor György and Seres András and Szalczer Lajos and Tóth-Molnár Edit and Vajas Attila and Varsány Balázs and Kerény Ágnes and Papp András and Szecskó Tímea and Vogt Gábor (kollab. közrem.): Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1‑year results from the Japan subgroup of the phase 3 YOSEMITE trial.
JAPANESE JOURNAL OF OPHTHALMOLOGY, 67 (3). pp. 264-279. ISSN 0021-5155 (2023)

[thumbnail of JapaneseJ.ofophthalmol.pdf] Text
JapaneseJ.ofophthalmol.pdf - Published Version

Download (1MB)
Item Type: Journal Article
Szerzők száma: 353
Journal or Publication Title: JAPANESE JOURNAL OF OPHTHALMOLOGY
Date: 2023
Volume: 67
Number: 3
Page Range: pp. 264-279
ISSN: 0021-5155
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 33916438
DOI azonosító: https://doi.org/10.1007/s10384-023-00979-8
Date Deposited: 2023. May. 31. 09:28
Last Modified: 2023. Jun. 02. 21:36
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/27308
Web of Science® Times Cited: 1 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year